Deepa Magge, MD, is an Assistant Professor of Surgery in the Division of Surgical Oncology and Endocrine Surgery at the Vanderbilt University Medical Center. Dr. Magge earned her bachelor degree with summa cum laude distinction in 2004 and medical degree with cum laude and AOA designation in 2008 from Boston University where she was part of their seven-year medical program.

Dr. Magge completed her General Surgery residency at the University of Pittsburgh Medical Center (UPMC) where she served as Administrative Chief Resident. During her residency, she performed 2 years of basic science and translational research, focusing on oncolytic viral therapy modulation, and was awarded the Resident Research award. Dr. Magge also completed numerous clinical research studies describing regional therapies, including Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for carcinomatosis secondary to multiple GI malignancies, as well as Isolated Hepatic Perfusion for unresectable liver metastases. Following completion of surgical residency, she remained at UPMC, where she completed a fellowship in Complex Surgical Oncology, during which she served as Administrative Chief Fellow. Following fellowship, she was an Assistant Professor of Surgery in the Division of Surgical Oncology at the Icahn School of Medicine at Mount Sinai in New York. She served as the Associate Program Director of the CGSO fellowship and focused much of her time on teaching residents and fellows. She was even awarded the Resident Teaching award during her tenure at Mount Sinai. She has over 20 first or last author publications as well as many other publications as collaborating author in peer-reviewed scientific and clinical journals and has presented her research findings nationally. She will serve as a committee member for the Advanced Cancer Therapies Conference offered by the Society of Surgical Oncology as well as a committee member for the Peritoneal Surface Malignancy Working Group for SSO, beginning her 2-year commitments this spring.

Dr. Magge’s specific areas of interest include gastrointestinal (GI) surgical oncology, colorectal surgery, and cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis. She is well-versed in Minimally Invasive approaches, including laparoscopic and robotic techniques, to treat most benign and malignant conditions. She is currently board certified in General Surgery as well as Complex General Surgical Oncology.